Virbac SA

Paris Stock Exchange VIRP.PA

Virbac SA Receivables for the year ending December 31, 2023: USD 265.02 M

Virbac SA Receivables is USD 265.02 M for the year ending December 31, 2023, a 23.50% change year over year. Receivables are the amounts owed to the company by customers for goods sold or services rendered.

Virbac SA Receivables for the year ending December 31, 2022 was USD 214.59 M, a 14.22% change year over year.
Virbac SA Receivables for the year ending December 31, 2021 was USD 187.88 M, a -5.13% change year over year.
Virbac SA Receivables for the year ending December 31, 2020 was USD 198.05 M, a 25.32% change year over year.
Virbac SA Receivables for the year ending December 31, 2019 was USD 158.03 M, a -1.98% change year over year.

Key data

Date	Receivables	Inventory	Goodwill	Total Assets

Paris Stock Exchange: VIRP.PA

Virbac SA

CEO	Mr. Habib Ramdani
IPO Date	July 7, 1992
Location	France
Headquarters	13e rue LID - BP 27
Employees	5,459
Sector	Consumers Staples
Industries Pet Food Agriculture Cosmetics Personal Care Pharmaceuticals

Description

Virbac SA manufactures and sells a range of products and services for companion and food-producing animals in France, Europe, Latin America, North America, the Asia Pacific, the Middle East, and Africa. The company offers a range of vaccines, dental hygiene, reproduction, dermatology, parasiticides, diagnostic, antibiotics, and aquaculture products; and veterinary medicines for anesthesia, geriatrics, behavior, and injectable micronutrients, as well as petfood and electronic identification. It serves veterinarians, farmers, and pet owners. Virbac SA was founded in 1968 and is headquartered in Carros, France.

Key trends

Past 5 years